rs421262

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 3P and 20B. PM1PP2BP4_StrongBP6_Very_StrongBA1

The NM_000153.4(GALC):​c.1921A>G​(p.Thr641Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.991 in 1,609,350 control chromosomes in the GnomAD database, including 790,270 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.

Frequency

Genomes: 𝑓 0.96 ( 69977 hom., cov: 31)
Exomes 𝑓: 0.99 ( 720293 hom. )

Consequence

GALC
NM_000153.4 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 0.659

Publications

40 publications found
Variant links:
Genes affected
GALC (HGNC:4115): (galactosylceramidase) This gene encodes a lysosomal protein which hydrolyzes the galactose ester bonds of galactosylceramide, galactosylsphingosine, lactosylceramide, and monogalactosyldiglyceride. Mutations in this gene have been associated with Krabbe disease, also known as globoid cell leukodystrophy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
GALC Gene-Disease associations (from GenCC):
  • Krabbe disease
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), Myriad Women's Health

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000153.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

PM1
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_000153.4
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 94 curated pathogenic missense variants (we use a threshold of 10). The gene has 16 curated benign missense variants. Gene score misZ: 0.18582 (below the threshold of 3.09). Trascript score misZ: -0.28853 (below the threshold of 3.09). GenCC associations: The gene is linked to Krabbe disease.
BP4
Computational evidence support a benign effect (MetaRNN=9.753622E-7).
BP6
Variant 14-87934869-T-C is Benign according to our data. Variant chr14-87934869-T-C is described in ClinVar as Benign. ClinVar VariationId is 92500.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000153.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALC
NM_000153.4
MANE Select
c.1921A>Gp.Thr641Ala
missense
Exon 17 of 17NP_000144.2P54803-1
GALC
NM_001201401.2
c.1852A>Gp.Thr618Ala
missense
Exon 16 of 16NP_001188330.1P54803-3
GALC
NM_001201402.2
c.1843A>Gp.Thr615Ala
missense
Exon 17 of 17NP_001188331.1P54803-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GALC
ENST00000261304.7
TSL:1 MANE Select
c.1921A>Gp.Thr641Ala
missense
Exon 17 of 17ENSP00000261304.2P54803-1
GALC
ENST00000921945.1
c.1882A>Gp.Thr628Ala
missense
Exon 16 of 16ENSP00000592004.1
GALC
ENST00000950382.1
c.1855A>Gp.Thr619Ala
missense
Exon 17 of 17ENSP00000620441.1

Frequencies

GnomAD3 genomes
AF:
0.957
AC:
145494
AN:
151984
Hom.:
69937
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.861
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.984
Gnomad ASJ
AF:
0.998
Gnomad EAS
AF:
0.937
Gnomad SAS
AF:
0.994
Gnomad FIN
AF:
1.00
Gnomad MID
AF:
0.997
Gnomad NFE
AF:
0.999
Gnomad OTH
AF:
0.962
GnomAD2 exomes
AF:
0.985
AC:
243168
AN:
246956
AF XY:
0.988
show subpopulations
Gnomad AFR exome
AF:
0.858
Gnomad AMR exome
AF:
0.992
Gnomad ASJ exome
AF:
0.998
Gnomad EAS exome
AF:
0.939
Gnomad FIN exome
AF:
1.00
Gnomad NFE exome
AF:
1.00
Gnomad OTH exome
AF:
0.991
GnomAD4 exome
AF:
0.994
AC:
1448476
AN:
1457248
Hom.:
720293
Cov.:
36
AF XY:
0.995
AC XY:
721390
AN XY:
725246
show subpopulations
African (AFR)
AF:
0.854
AC:
28450
AN:
33330
American (AMR)
AF:
0.991
AC:
44173
AN:
44580
Ashkenazi Jewish (ASJ)
AF:
0.998
AC:
26003
AN:
26048
East Asian (EAS)
AF:
0.953
AC:
37799
AN:
39658
South Asian (SAS)
AF:
0.997
AC:
85958
AN:
86176
European-Finnish (FIN)
AF:
1.00
AC:
53364
AN:
53364
Middle Eastern (MID)
AF:
0.990
AC:
5691
AN:
5746
European-Non Finnish (NFE)
AF:
1.00
AC:
1107686
AN:
1108132
Other (OTH)
AF:
0.986
AC:
59352
AN:
60214
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
434
868
1302
1736
2170
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21564
43128
64692
86256
107820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.957
AC:
145594
AN:
152102
Hom.:
69977
Cov.:
31
AF XY:
0.958
AC XY:
71238
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.861
AC:
35725
AN:
41490
American (AMR)
AF:
0.984
AC:
15014
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.998
AC:
3463
AN:
3470
East Asian (EAS)
AF:
0.937
AC:
4813
AN:
5134
South Asian (SAS)
AF:
0.995
AC:
4801
AN:
4826
European-Finnish (FIN)
AF:
1.00
AC:
10608
AN:
10608
Middle Eastern (MID)
AF:
0.997
AC:
293
AN:
294
European-Non Finnish (NFE)
AF:
0.999
AC:
67933
AN:
67996
Other (OTH)
AF:
0.963
AC:
2032
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
292
583
875
1166
1458
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.985
Hom.:
148892
Bravo
AF:
0.950
Asia WGS
AF:
0.960
AC:
3340
AN:
3478
EpiCase
AF:
0.999
EpiControl
AF:
0.999

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
Galactosylceramide beta-galactosidase deficiency (5)
-
-
4
not provided (4)
-
-
3
not specified (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.57
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
0.13
DANN
Benign
0.15
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.010
N
LIST_S2
Benign
0.035
T
MetaRNN
Benign
9.8e-7
T
MetaSVM
Benign
-0.95
T
PhyloP100
0.66
PrimateAI
Benign
0.28
T
PROVEAN
Benign
1.4
N
REVEL
Benign
0.26
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Varity_R
0.028
gMVP
0.60
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs421262;
hg19: chr14-88401213;
COSMIC: COSV107205313;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.